glp-1 drugs breastfeeding GLP-1s and — Bridges Lactation GLP-1 and Breastfeeding: Safety Evidence

People often see corporate medical research as different from academic research and while the goal is slightly differentproducing a medicine versus focusing on advancing knowledgethe science is driven by the same factors: opportunity, curiosity and leveraging whats available

How Do They Work for Weight Loss

Again, the WD+allulose group showed a significant reduction in food intake compared to the WD+stevia group

Clemmensen C, Finan B, Mller TD, DiMarchi RD, Tschp MH, Hofmann SM (2019) Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases

Enebo LB, Berthelsen KK, Kankam M, Lund MT, Rubino DM, Satylganova A, et al

Among the two incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), the latter has been established as having therapeutic potential for reducing elevated plasma glucose (1, 2) and body weight (3), while the former has been unable to either stimulate insulin secretion (1) or lower plasma glucose effectively in type 2 diabetes (T2D) (4)